Between 5-10% of BCs are attributed to inherited genetic variations mainly in two high-risk genes, BRCA1 and BRCA2, associated to the hereditary breast and ovarian cancer syndrome (HBOC), which confer a high risk of breast, ovarian, pancreatic and prostate cancer (2–4). Here, BRCA2 is linked to prostate carcinoma.